Department of Radiology and Radiological Sciences
Sandler Lecture in Nuclear Medicine and Molecular Imaging
"A Tour of Prostate Cancer Theranostics"
featuring
Hossein Jadvar, M.D., Ph.D., MPH, MBA, FACNM, FSNMMI
Associate Professor of Radiology, Keck School of Medicine
Associate Professor of Biomedical Engineering, Viterbi School of Engineering
University of Southern California
Los Angeles, California
Monday, September 17, 2018 | Noon - 1 p.m.
MCN CCC-1111
View/Download Grand Rounds Poster Here
---------------------------------------------------------------
This grand round is designed for faculty, residents, staff and medical students.
Learning objectives of this presentation include the following:
1. Define and review briefly the history of theranostics.
2. Describe role of imaging in relation to natural history of prostate cancer
3. Review PET radiotracers used in the imaging evaluation of prostate cancer
4. Describe potential role of targeted radionuclide therapy in metastatic prostate cancer
+++
Dr. Hossein Jadvar is a tenured associate professor of radiology and biomedical engineering at the University of Southern California (USC) in Los Angeles, California. He received his B.S. in chemical engineering from Iowa State University in Ames, IA, in 1982, followed by a M.S. in biomedical engineering from the University of Wisconsin in Madison, WI, in 1984, and a M.S. in computer engineering, as well as a Ph.D. in bioengineering, both from the University of Michigan in Ann Arbor, MI, in 1986 and 1988, respectively. He then attended the University of Chicago, Pritzker School of Medicine, in Chicago, IL, for his M.D. degree (1993). He received his master’s in public health (MPH) degree from Harvard University in Cambridge, MA, in 2005 and an Executive master’s in business administration (MBA) from USC in 2007. He was an intern in internal medicine at the University of California San Francisco, CA, during 1993-94, a diagnostic radiology and nuclear medicine resident at Stanford University, in Stanford, CA, during 1994-98, and a clinical fellow in positron emission tomography with the Harvard Medical School Joint Program in Nuclear Medicine, in Boston, MA, during 1998-99. He has also completed a number of executive educational certificate programs at Harvard Medical School in Boston, MA, the University of Cambridge in the UK, the University of Oxford in the UK, and the Wharton School of Business at the University of Pennsylvania in Philadelphia, PA. He has served as a visiting associate in bioengineering at the California Institute of Technology (Caltech) in Pasadena, CA. Dr. Jadvar is on the leadership editorial boards of the Journal of Nuclear Medicine, the European Journal of Nuclear Medicine and Molecular Imaging, Molecular Imaging and Biology, Radiology (Consultant to the Editor), American Journal of Roentgenology (Assistant Editor), and Clinical Nuclear Medicine (Deputy Editor), and is on the editorial board of many other journals. He is a fellow and past president of the American College of Nuclear Medicine (ACNM) as well as past president and fellow of the Society of Nuclear Medicine and molecular imaging (SNMMI). He is the past recipient of the SNMMI Mark Tetalman Young Investigator Award, the Western Regional SNMMI Distinguished Scientist Award, the Academy of Radiology Research Distinguished Investigator Award, and the inaugural Prof. Ajit Padhy Oration Award from the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH), and the Best Clinical Mentor Award from the ACNM. He is a National Institutes of Health (NIH) funded investigator and serves on multiple NIH review panels (with one term as a chartered member on the medical imaging, MEDI, panel), the Department of Defense, and the Imaging Technology and Informatics Peer Review Panel of the Cancer Prevention and Research Institute of Texas (CPRIT). He is an International Atomic Energy Agency (IAEA) expert on the nuclear medicine panel. He has written more than 120 journal articles, has published 4 books, 28 book chapters, 9 patents, numerous conference abstracts and full articles, and has given more than 250 invited speaker presentations at national and international venues. His research interests include applications of PET in clinical outcome research and in translational molecular imaging research with particular current interest in prostate cancer.